Hypotrichosis
MONDO:0003037A congenital condition, usually due to genetic aberrations, that is characterized by a lack of hair growth on the head and/or body.
6 clinical trials for this condition and its sub-types, 5 tagged with Hypotrichosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hypotrichosis
-
Hypotrichosis of eyelid 2 trials
-
Basaran Yilmaz syndrome 0 trials
-
Marie Unna hereditary hypotrichosis 0 trials
2 sub-types
- Hypotrichosis 4 0 trials
- Hypotrichosis 5 0 trials
-
Congenital hypotrichosis milia 0 trials
-
Hypotrichosis 1 0 trials
-
Hypotrichosis 10 0 trials
-
Hypotrichosis 11 0 trials
-
Hypotrichosis 12 0 trials
-
Hypotrichosis 13 0 trials
-
Hypotrichosis 14 0 trials
-
Hypotrichosis 15 0 trials
-
Hypotrichosis 16 0 trials
-
Hypotrichosis 2 0 trials
-
Hypotrichosis 3 0 trials
-
Hypotrichosis 6 0 trials
-
Hypotrichosis 7 0 trials
-
Hypotrichosis 8 0 trials
-
Hypotrichosis 9 0 trials
-
New hope for kids with severe hair loss: baricitinib pill tested in major trial
Disease control Recruiting nowThis study tests whether baricitinib, a daily pill, can safely regrow hair in children aged 6 to 17 with severe alopecia areata (patchy hair loss). About 595 kids will receive either the drug or a placebo for 36 weeks, then all can get the drug for up to 2 years. The goal is to s…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug could help regrow hair in severe alopecia
Disease control Recruiting nowThis study tests a drug called LAD603 in 136 adults with severe to very severe alopecia areata, a condition causing significant hair loss. Participants will receive either the drug or a placebo to see if it helps regrow hair and is safe. The main goal is to measure changes in hai…
Phase 2 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC